Evidence map›Paper›PMID 15855503›Full record

ArticleAntimicrobial agents and chemotherapy2005

Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection.

Shuwen Liu, Hong Lu, A Robert Neurath, Shibo Jiang

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Amphipathic properties of HIV-1 gp41 fusion inhibitors.Current topics in medicinal chemistry · 2011
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Microbicides: stopping HIV at the gate.Lancet (London, England) · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shuwen LiuLindsley F. Kimball Research Institute, New York Blood Center, 310 E 67th St., New York, NY 10021, USA.
Hong Lu
A Robert Neurath
Shibo Jiang
New York Blood Center · US

Funding

SAFETY AND EFFICACY OF CAP IN VIVOP01HD041761 · NICHD · NEW YORK BLOOD CENTER · PI NEURATH, A ROBERT ROBERT · 2001 to 2004
$4.2M
In vivo Safety and Efficacy of CAP and Combination FilmsU19HD048957 · NICHD · NEW YORK BLOOD CENTER · PI JIANG, SHIBO · 2004 to 2006
$3.9M
In vivo Safety and Efficacy of CAP and Combination FilmsU19AI076964 · NIAID · NEW YORK BLOOD CENTER · PI NEURATH, A ROBERT ROBERT · 2007 to 2008
$2.3M
NIAID NIH HHS U19 AI076964NICHD NIH HHS HD41761NICHD NIH HHS HD48957NICHD NIH HHS P01 HD041761NICHD NIH HHS U19 HD048957
6 · The paper itself

Abstract

The combination of two candidate microbicides, cellulose acetate 1,2-benzenedicarboxylate (CAP), a polymer that blocks human immunodeficiency virus type 1 (HIV-1) entry by targeting gp120 and gp41, and UC781, a tight-binding HIV-1 reverse transcriptase inhibitor (RTI), resulted in effective synergy for inhibition of MT-2 cell infection by HIV-1(IIIB), a laboratory-adapted virus strain. The 95% effective concentration values for the combination were reduced about 15- to 20-fold compared with those corresponding to the single compounds. The combination of CAP and UC781 is also synergistic in inhibiting infection of peripheral blood mononuclear cells by a primary HIV-1 isolate, 92US657. Combinations of CAP with other RTIs, such as efavirenz or zidovudine, also had significant synergistic effects on the inhibition of HIV-1 infection. In addition, CAP and UC781 had complementary effects against HIV-1 infection since (i) CAP inhibited infection by the UC781-resistant strain HIV-1(IIIB) A17 and (ii) pretreatment of MT-2 cells with UC781, but not CAP, abolished subsequent infection after removal of the compound. This suggests that the combination of CAP and UC781 represents a promising candidate microbicide for prevention of sexual transmission of HIV-1.

Indexed as

Anti-HIV AgentsAnilidesCell LineCell SurvivalCelluloseDrug SynergismFuransHIV-1HIV Core Protein p24HIV InfectionsHumansThioamidesAnilidesAnti-HIV AgentsCellulosecellulose acetate 1,2-benzenedicarboxylateFuransHIV Core Protein p24ThioamidesUC-781

Identifiers

PMID15855503
PMCPMC1087640
OpenAlexW2097903159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.